What is a primary mediastinal germ cell tumour?
A primary mediastinal germ cell tumour is a growth made of germ cells, the cells that normally develop into sperm or eggs, which arises in the mediastinum. The mediastinum is the central part of the chest that lies between the lungs and contains the heart, the windpipe, the gullet and large blood vessels. Most of these tumours grow in the front (anterior) part of the mediastinum, just behind the breastbone.
Germ cell tumours usually start in the testes or ovaries. Occasionally they appear elsewhere along the midline of the body, for example in the chest, at the back of the abdomen or in the brain. Experts believe this happens because some germ cells stray from their normal path while the embryo is developing and settle in the wrong place (El-Zaatari and Ro, 2021). When a germ cell tumour arises outside the gonads, the chest is the most common site.
These tumours mostly affect young men, typically in their 20s and 30s. They range from benign mature teratomas, which are cured by surgery alone, to aggressive non-seminomatous cancers. Treatment for the malignant forms combines chemotherapy and surgery, and many patients are cured. However, the non-seminoma group has the poorest outlook of all germ cell tumours (Ozgun and Nappi, 2023).
This article explains the different types, how they are diagnosed and treated, and what to expect afterwards.
1. Key facts at a glance
| Feature | Details |
|---|---|
| Where it grows | Anterior mediastinum, behind the breastbone |
| Who is affected | Mainly young men; mean age around 29 years in a large surgical series |
| Main groups | Teratoma, seminoma, non-seminomatous germ cell tumour |
| Genetic hallmark | Extra copies of chromosome 12p, often as isochromosome 12p |
| Linked conditions | Klinefelter syndrome |
| Blood tumour markers | AFP, beta-hCG and LDH |
| Main treatment | Chemotherapy, then surgery to remove remaining tumour |
| Benign teratoma | Surgery alone |
| Outlook | Good for seminoma; poorer for non-seminoma |
2. Types
Mediastinal germ cell tumours are classified in the same way as testicular germ cell tumours (El-Zaatari and Ro, 2021).
| Type | Description | Typical behaviour |
|---|---|---|
| Mature teratoma | Contains well-formed tissues such as skin, hair, fat and teeth | Benign; cured by removal |
| Immature teratoma | Contains embryonic-looking tissue | Behaviour depends on the amount of immature tissue |
| Seminoma | Pure seminoma | Very sensitive to chemotherapy; survival similar to testicular seminoma |
| Yolk sac tumour | Often produces AFP | Aggressive |
| Embryonal carcinoma | Primitive cells | Aggressive |
| Choriocarcinoma | Produces high beta-hCG | Aggressive; tends to spread through the blood |
| Mixed germ cell tumour | Combination of the above | Treated as non-seminoma |
Seminoma versus non-seminoma
| Feature | Seminoma | Non-seminoma |
|---|---|---|
| AFP level | Normal | Often raised |
| Beta-hCG level | Normal or mildly raised | May be high |
| Response to chemotherapy | Excellent | Good, but residual masses are common |
| Need for surgery after chemotherapy | Less often | Usually |
| IGCCCG risk group | Good or intermediate | Poor risk by definition |
Non-seminomas of the mediastinum are placed in the poor-risk group of the International Germ Cell Cancer Collaborative Group (IGCCCG) whatever their marker levels (Rosti et al., 2019).
Other cancers that can develop
Rarely, a mediastinal germ cell tumour gives rise to a different kind of cancer, such as a sarcoma or carcinoma within a teratoma (somatic-type malignancy). A blood cancer, such as leukaemia, can also occur in association with these tumours (El-Zaatari and Ro, 2021). Such complications are uncommon but affect treatment and outlook.
3. Causes and risk factors
| Risk factor | Notes |
|---|---|
| Male sex | Malignant forms occur mostly in men |
| Young adult age | Peak in the third and fourth decades |
| Klinefelter syndrome | A chromosomal condition (47,XXY) linked with a higher risk |
| Abnormal germ cell migration | Thought to underlie all extragonadal germ cell tumours |
Most people with this tumour have no known risk factor. It is not caused by lifestyle and is not passed on in families in most cases. Doctors will usually examine the testes and arrange an ultrasound, because a testicular primary that has spread to the chest must be ruled out.
4. How does it look
On scans
| Test | Typical findings |
|---|---|
| Chest X-ray | A widened central shadow in the chest |
| CT of the chest | A large mass in the front of the chest |
| Mature teratoma on CT | Mixture of fat, fluid and calcium, sometimes teeth |
| Seminoma on CT | A fairly uniform solid mass |
| Non-seminoma on CT | Irregular mass with areas of bleeding or dead tissue; may invade nearby structures |
| PET-CT | Useful in seminoma after chemotherapy |
| Testicular ultrasound | Excludes a primary tumour in the testis |
Under the microscope
| Feature | What the pathologist looks for |
|---|---|
| Cell pattern | Identifies seminoma, yolk sac tumour, embryonal carcinoma, choriocarcinoma or teratoma |
| Immunostains | Markers such as SALL4, OCT3/4, CD117, glypican-3 and CD30 help separate the types |
| 12p status | Confirms germ cell origin when the pattern is unusual |
| Somatic elements | Detects sarcoma or carcinoma within a teratoma |
5. Symptoms
Small tumours may cause no symptoms and be found on a chest X-ray done for another reason. Larger tumours press on structures in the chest.
Common symptoms
- Chest pain or a feeling of pressure
- Cough
- Breathlessness
- Fever, night sweats or weight loss
Less common symptoms
| Symptom | Possible cause |
|---|---|
| Swelling of the face, neck and arms | Pressure on the superior vena cava (SVC obstruction) |
| Hoarse voice | Pressure on the nerve to the voice box |
| Coughing up blood | Invasion of the airway or lung |
| Breast enlargement in men | High beta-hCG levels |
| Coughing up hair or fatty material | A teratoma that has opened into the airway (rare) |
When to seek urgent help
Get urgent medical help if you notice sudden swelling of the face or neck, severe breathlessness, or difficulty breathing when lying flat.
6. Diagnosis
| Test | Purpose |
|---|---|
| CT of the chest, abdomen and pelvis | Size of the mass and spread |
| Blood tumour markers (AFP, beta-hCG, LDH) | Help with diagnosis, risk grouping and monitoring |
| Biopsy | Usually a needle biopsy guided by CT |
| Testicular examination and ultrasound | Rules out a testicular primary |
| MRI of the brain | If symptoms suggest brain spread or markers are very high |
| Lung function tests | Before chemotherapy and surgery |
| Chromosome test | When Klinefelter syndrome is suspected |
| Sperm banking | Offered before chemotherapy |
In some very urgent situations, with very high markers and a typical scan, doctors may start chemotherapy before a biopsy is taken.
Risk grouping
| IGCCCG group | Mediastinal seminoma | Mediastinal non-seminoma |
|---|---|---|
| Good risk | No spread to organs other than the lungs | Not applicable |
| Intermediate risk | Spread to organs other than the lungs | Not applicable |
| Poor risk | Not applicable | All cases |
7. Treatment
Because the disease is rare, there are no prospective trials comparing treatments, and patients are treated using the general principles for germ cell tumours (Rosti et al., 2019). Care should be given in a centre with germ cell tumour expertise.
Treatment by tumour type
| Tumour type | Usual approach |
|---|---|
| Mature teratoma | Surgical removal alone, without chemotherapy |
| Seminoma | Cisplatin-based chemotherapy; surgery or radiotherapy is rarely needed |
| Non-seminoma | Cisplatin-based chemotherapy, then surgery to remove any remaining mass |
| Somatic-type malignancy | Surgery, plus treatment directed at the specific cancer type |
Chemotherapy
| Regimen | Notes |
|---|---|
| BEP (bleomycin, etoposide, cisplatin) | Standard for many germ cell tumours |
| VIP (etoposide, ifosfamide, cisplatin) | Often preferred for mediastinal non-seminoma because it avoids bleomycin |
| EP (etoposide, cisplatin) | An option for some seminomas |
| High-dose chemotherapy with stem cell rescue | Used in some relapsed cases |
Bleomycin can damage the lungs. In one centre’s series of 255 operated patients, serious lung injury after surgery (acute respiratory distress syndrome) occurred in about 1 in 9 and was considerably more frequent after bleomycin-containing treatment (Kesler et al., 2021). The authors recommend avoiding bleomycin before chest surgery.
Surgery after chemotherapy
After chemotherapy, the blood markers usually fall, but a mass often remains. Surgeons remove this residual mass, typically through a sternotomy (an incision through the breastbone) or a clamshell incision. The operation may involve removing part of a lung, the pericardium or large blood vessels.
| What is found in the remaining mass | Share in the Kesler series | Meaning |
|---|---|---|
| Dead tissue (necrosis) only | About 25% | Best outlook |
| Teratoma | About 34% | Removal is essential, as teratoma does not respond to chemotherapy |
| Active cancer | About 40% | Poorer outlook; further treatment may be needed |
Treatment timeline for non-seminoma
| Phase | What happens | Typical length |
|---|---|---|
| Diagnosis and staging | Scans, markers, biopsy, sperm banking | 1-2 weeks |
| Chemotherapy | Usually four cycles, each lasting three weeks | About 3 months |
| Recovery and re-staging | Repeat scans and markers | 3-6 weeks |
| Surgery | Removal of the remaining mass | Hospital stay of about a week |
| Further treatment if needed | More chemotherapy if active cancer remains | Varies |
Side effects
| Treatment | Possible side effects |
|---|---|
| Chemotherapy | Tiredness, infection risk, nausea, hair loss, hearing loss, tingling in hands and feet, kidney effects, reduced fertility |
| Bleomycin | Lung scarring |
| Ifosfamide | Bladder irritation, confusion, kidney effects |
| Chest surgery | Pain, breathing problems, bleeding, nerve injury affecting the voice or diaphragm |
8. Outlook (prognosis)
| Factor | Effect |
|---|---|
| Seminoma | Outlook similar to testicular seminoma |
| Non-seminoma | The poorest survival of all germ cell tumour presentations |
| Choriocarcinoma before chemotherapy | Linked with worse survival |
| Seminoma elements in a non-seminoma | Linked with better survival |
| Necrosis only in the residual mass | Better survival |
| Active cancer in more than half the residual mass | Roughly doubled risk of death |
| Raised markers after surgery | Strong predictor of poorer survival |
The figures come from Ozgun and Nappi (2023) and Kesler et al. (2021). Better treatments for non-seminoma, both first-line and at relapse, are still needed (Ozgun and Nappi, 2023).
9. Follow-up
| Time after treatment | Typical checks |
|---|---|
| Years 1-2 | Clinic visit and tumour markers every 1-3 months; chest imaging every 3-6 months |
| Years 3-5 | Visits and markers every 4-6 months; imaging less often |
| After 5 years | Yearly review, including long-term effects |
Long-term effects to monitor
| Effect | What to watch for |
|---|---|
| Hearing loss and tinnitus | Hearing tests if symptoms appear |
| Nerve damage | Numbness or tingling |
| Heart and blood vessel risk | Blood pressure, cholesterol and weight checks |
| Low testosterone | Tiredness, low mood, low libido |
| Second cancers, including blood cancers | Regular blood counts |
10. Living with a mediastinal germ cell tumour
- Bank sperm before chemotherapy if you may want children
- Tell doctors about bleomycin before any future anaesthetic, as high oxygen levels can harm lungs exposed to it
- Stop smoking to protect your lungs and heart
- Build up activity gradually after chest surgery, with physiotherapy if offered
- Keep follow-up appointments, as relapse is most likely in the first two years
- Look after your heart health with exercise and a balanced diet
- Seek support from testicular and germ cell cancer charities
11. Frequently asked questions
| Question | Answer |
|---|---|
| Is it testicular cancer? | No, it starts in the chest, but it is related and treated in a similar way |
| Is a teratoma cancer? | A mature teratoma is benign and is cured by surgery |
| Why do I need surgery after chemotherapy worked? | The leftover mass may contain teratoma or active cancer |
| Why are my blood markers checked so often? | Rising AFP or beta-hCG is an early sign of relapse |
| Can women get it? | Yes, but malignant forms are much more common in men |
| Will I be able to have children? | Many men father children; sperm banking is advised |
| Can it come back? | Yes, most often within two years |
12. Questions to ask your care team
- Is my tumour a teratoma, seminoma or non-seminoma?
- What are my tumour marker levels, and what is my risk group?
- Which chemotherapy do you recommend, and will it include bleomycin?
- Will I need surgery, and what will it involve?
- How can I protect my fertility?
- Should I be tested for Klinefelter syndrome?
- What follow-up will I have?
Resources
- El-Zaatari, Z.M. and Ro, J.Y. (2021) ‘Mediastinal germ cell tumors: a review and update on pathologic, clinical, and molecular features’, Advances in Anatomic Pathology, 28(5), pp. 335-350.
- Kesler, K.A. et al. (2021) ‘Outcomes following surgery for primary mediastinal nonseminomatous germ cell tumors in the cisplatin era’, Journal of Thoracic and Cardiovascular Surgery, 161(6), pp. 1947-1959.e1.
- Ozgun, G. and Nappi, L. (2023) ‘Primary mediastinal germ cell tumors: a thorough literature review’, Biomedicines, 11(2), 487.
- Rosti, G. et al. (2019) ‘Primary mediastinal germ cell tumors’, Seminars in Oncology, 46(2), pp. 107-111.
- National Cancer Institute (2026) Testicular Cancer Treatment (PDQ) – Health Professional Version. Available at: https://www.cancer.gov/types/testicular/hp/testicular-treatment-pdq (Accessed: October 2026).
Prepared by the editorial team, October 2026.